Cargando…
Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
Therapy for multiple myeloma (MM), a hematologic neoplasm of plasma cells, has undergone remarkable changes over the past 25 years. Small molecules (molecular weight of less than one kDa), together with newer immunotherapies that include monoclonal antibodies, antibody-drug conjugates, and most rece...
Autor principal: | Abramson, Hanley N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917049/ https://www.ncbi.nlm.nih.gov/pubmed/36768967 http://dx.doi.org/10.3390/ijms24032645 |
Ejemplares similares
-
Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018) -
Kinase inhibitors as potential agents in the treatment of multiple myeloma
por: Abramson, Hanley N.
Publicado: (2016) -
Immunotherapy of Multiple Myeloma: Promise and Challenges
por: Abramson, Hanley N
Publicado: (2021) -
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
por: Abramson, Hanley N.
Publicado: (2023) -
Recent Advances in the Treatment of Patients with Multiple Myeloma
por: Legarda, Mario A., et al.
Publicado: (2020)